{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:38:13Z","timestamp":1789184293808,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"The Center for Drug Reevaluation, NMPA","award":["CDRZ20234001-2"],"award-info":[{"award-number":["CDRZ20234001-2"]}]},{"name":"Ab&B Biotech Co., Ltd."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s40121-026-01354-z","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T11:35:59Z","timestamp":1778240159000},"page":"1763-1778","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Post-Marketing Active Surveillance of Adverse Events Following Quadrivalent Subunit Influenza Vaccine in Healthy Participants Aged\u2009\u2265\u20093 Years in China"],"prefix":"10.1007","volume":"15","author":[{"given":"Mingwei","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaowen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengqiang","family":"Kou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jikai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kezhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youcai","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuyang","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxing","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"1354_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvacx.2024.100452","volume":"17","author":"S Malik","year":"2024","unstructured":"Malik S, Asghar M, Waheed Y. Outlining recent updates on influenza therapeutics and vaccines: a comprehensive review. Vaccine X. 2024;17:100452. https:\/\/doi.org\/10.1016\/j.jvacx.2024.100452.","journal-title":"Vaccine X"},{"issue":"10127","key":"1354_CR2","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","volume":"391","author":"AD Iuliano","year":"2018","unstructured":"Iuliano AD, Roguski KM, Chang HH, et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet. 2018;391(10127):1285\u2013300. https:\/\/doi.org\/10.1016\/S0140-6736(17)33293-2.","journal-title":"Lancet"},{"key":"1354_CR3","unstructured":"World Health Organization. Up to 650,000 people die of respiratory diseases linked to seasonal flu each year. http:\/\/www.who.int\/mediacentre\/news\/releases\/2017\/seasonal-flu\/en\/. Accessed Oct 10, 2025."},{"issue":"4 Suppl","key":"1354_CR4","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1097\/CCM.0b013e3181c92eeb","volume":"38","author":"MB Rothberg","year":"2010","unstructured":"Rothberg MB, Haessler SD. Complications of seasonal and pandemic influenza. Crit Care Med. 2010;38(4 Suppl):e91\u20137. https:\/\/doi.org\/10.1097\/CCM.0b013e3181c92eeb.","journal-title":"Crit Care Med"},{"issue":"3","key":"1354_CR5","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.tim.2022.09.015","volume":"31","author":"Z Zhu","year":"2023","unstructured":"Zhu Z, Fodor E, Keown JR. A structural understanding of influenza virus genome replication. Trends Microbiol. 2023;31(3):308\u201319. https:\/\/doi.org\/10.1016\/j.tim.2022.09.015.","journal-title":"Trends Microbiol"},{"issue":"8","key":"1354_CR6","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1007\/s00705-017-3358-5","volume":"162","author":"MJ Adams","year":"2017","unstructured":"Adams MJ, Lefkowitz EJ, King AMQ, et al. Changes to taxonomy and the International Code of Virus Classification and Nomenclature ratified by the International Committee on Taxonomy of Viruses. Arch Virol. 2017;162(8):2505\u201338. https:\/\/doi.org\/10.1007\/s00705-017-3358-5.","journal-title":"Arch Virol"},{"issue":"8","key":"1354_CR7","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.3201\/eid2408.180063","volume":"24","author":"J Yang","year":"2018","unstructured":"Yang J, Lau YC, Wu P, et al. Variation in influenza B virus epidemiology by lineage, China. Emerg Infect Dis. 2018;24(8):1536\u201340. https:\/\/doi.org\/10.3201\/eid2408.180063.","journal-title":"Emerg Infect Dis"},{"key":"1354_CR8","doi-asserted-by":"publisher","first-page":"1467029","DOI":"10.3389\/fmicb.2024.1467029","volume":"15","author":"MA Ashraf","year":"2024","unstructured":"Ashraf MA, Raza MA, Amjad MN, et al. A comprehensive review of influenza B virus, its biological and clinical aspects. Front Microbiol. 2024;15:1467029. https:\/\/doi.org\/10.3389\/fmicb.2024.1467029.","journal-title":"Front Microbiol"},{"issue":"21","key":"1354_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.126182","volume":"42","author":"Y Gao","year":"2024","unstructured":"Gao Y, Yang X, Li X, et al. Lot-to-lot consistency, immunogenicity and safety of a quadrivalent split virion inactivated influenza vaccine in healthy population aged 9\u201359 years: a randomized, double-blind, controlled, phase IV clinical trial. Vaccine. 2024;42(21):126182. https:\/\/doi.org\/10.1016\/j.vaccine.2024.126182.","journal-title":"Vaccine"},{"issue":"1","key":"1354_CR10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40794-024-00228-x","volume":"10","author":"Z Kou","year":"2024","unstructured":"Kou Z, Li X, Liu T, et al. A post-marketing study to evaluate the safety and immunogenicity of a quadrivalent influenza split-virion vaccine in elderly people aged 60 years and older. Trop Dis Travel Med Vaccines. 2024;10(1):18. https:\/\/doi.org\/10.1186\/s40794-024-00228-x.","journal-title":"Trop Dis Travel Med Vaccines"},{"key":"1354_CR11","doi-asserted-by":"publisher","unstructured":"Xia J, Zhao S, Wang P, et al. Post-marketing safety evaluation of quadrivalent influenza virus vaccine (split virion) in four regions. Prog Microbiol Immunol. 2022;50(02):41\u20136. https:\/\/doi.org\/10.13309\/j.cnki.pmi.2022.02.007.","DOI":"10.13309\/j.cnki.pmi.2022.02.007"},{"key":"1354_CR12","doi-asserted-by":"publisher","unstructured":"Liu Z, Meng R, Yang Y, et al. Active vaccine safety surveillance: global trends and challenges in China. Health Data Sci. 2021;2021:9851067. https:\/\/doi.org\/10.34133\/2021\/9851067.","DOI":"10.34133\/2021\/9851067"},{"issue":"Suppl 2","key":"1354_CR13","doi-asserted-by":"publisher","first-page":"S345","DOI":"10.2105\/AJPH.2008.143081","volume":"99","author":"MR Griffin","year":"2009","unstructured":"Griffin MR, Braun MM, Bart KJ. What should an ideal vaccine postlicensure safety system be? Am J Public Health. 2009;99(Suppl 2):S345\u201350. https:\/\/doi.org\/10.2105\/AJPH.2008.143081.","journal-title":"Am J Public Health"},{"issue":"36","key":"1354_CR14","doi-asserted-by":"publisher","first-page":"4398","DOI":"10.1016\/j.vaccine.2015.07.035","volume":"33","author":"TT Shimabukuro","year":"2015","unstructured":"Shimabukuro TT, Nguyen M, Martin D, DeStefano F. Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS). Vaccine. 2015;33(36):4398\u2013405. https:\/\/doi.org\/10.1016\/j.vaccine.2015.07.035.","journal-title":"Vaccine"},{"issue":"3","key":"1354_CR15","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1093\/inthealth\/ihx019","volume":"9","author":"P Cashman","year":"2017","unstructured":"Cashman P, Macartney K, Khandaker G, King C, Gold M, Durrheim DN. Participant-centred active surveillance of adverse events following immunisation: a narrative review. Int Health. 2017;9(3):164\u201376. https:\/\/doi.org\/10.1093\/inthealth\/ihx019.","journal-title":"Int Health"},{"issue":"3","key":"1354_CR16","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1179\/2046905513Y.0000000110","volume":"34","author":"HA Korkmaz","year":"2014","unstructured":"Korkmaz HA, Aydin A, Unal B. Comparison of acellular pertussis-tetanus-diphtheria vaccines and whole-cell pertussis-tetanus-diphtheria vaccines in infancy. Paediatr Int Child Health. 2014;34(3):198\u2013202. https:\/\/doi.org\/10.1179\/2046905513Y.0000000110.","journal-title":"Paediatr Int Child Health"},{"issue":"25","key":"1354_CR17","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1056\/NEJMoa1006736","volume":"363","author":"J Wu","year":"2010","unstructured":"Wu J, Xu F, Lu L, et al. Safety and effectiveness of a 2009 H1N1 vaccine in Beijing. N Engl J Med. 2010;363(25):2416\u201323. https:\/\/doi.org\/10.1056\/NEJMoa1006736.","journal-title":"N Engl J Med"},{"issue":"34","key":"1354_CR18","doi-asserted-by":"publisher","first-page":"4933","DOI":"10.1016\/j.vaccine.2022.06.078","volume":"40","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Wang Y, Jia C, et al. Immunogenicity and safety of an egg culture-based quadrivalent inactivated non-adjuvanted subunit influenza vaccine in subjects >\/=3 years: a randomized, multicenter, double-blind, active-controlled phase III, non-inferiority trial. Vaccine. 2022;40(34):4933\u201341. https:\/\/doi.org\/10.1016\/j.vaccine.2022.06.078.","journal-title":"Vaccine"},{"issue":"282","key":"1354_CR19","doi-asserted-by":"publisher","first-page":"20143085","DOI":"10.1098\/rspb.2014.3085","volume":"2015","author":"AK Simon","year":"1821","unstructured":"Simon AK, Hollander GA, McMichael A. Evolution of the immune system in humans from infancy to old age. Proc Biol Sci. 1821;2015(282):20143085. https:\/\/doi.org\/10.1098\/rspb.2014.3085.","journal-title":"Proc Biol Sci"},{"issue":"1","key":"1354_CR20","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41746-024-01323-1","volume":"7","author":"Y Kawazoe","year":"2024","unstructured":"Kawazoe Y, Shimamoto K, Seki T, et al. Post-marketing surveillance of anticancer drugs using natural language processing of electronic medical records. NPJ Digit Med. 2024;7(1):315. https:\/\/doi.org\/10.1038\/s41746-024-01323-1.","journal-title":"NPJ Digit Med"},{"key":"1354_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9090998","author":"G Perego","year":"2021","unstructured":"Perego G, Vigezzi GP, Cocciolo G, et al. Safety and efficacy of spray intranasal live attenuated influenza vaccine: systematic review and meta-analysis. Vaccines (Basel). 2021. https:\/\/doi.org\/10.3390\/vaccines9090998.","journal-title":"Vaccines (Basel)."},{"issue":"28","key":"1354_CR22","doi-asserted-by":"publisher","first-page":"3722","DOI":"10.1016\/j.vaccine.2019.05.013","volume":"37","author":"C Nicolodi","year":"2019","unstructured":"Nicolodi C, Groiss F, Kiselev O, Wolschek M, Seipelt J, Muster T. Safety and immunogenicity of a replication-deficient H5N1 influenza virus vaccine lacking NS1. Vaccine. 2019;37(28):3722\u20139. https:\/\/doi.org\/10.1016\/j.vaccine.2019.05.013.","journal-title":"Vaccine"},{"key":"1354_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9121388","author":"J Eiden","year":"2021","unstructured":"Eiden J, Gordon G, Fierro C, et al. Safety and immunogenicity of M2-deficient, single replication, live influenza vaccine (M2SR) in adults. Vaccines (Basel). 2021. https:\/\/doi.org\/10.3390\/vaccines9121388.","journal-title":"Vaccines (Basel)."},{"issue":"36","key":"1354_CR24","doi-asserted-by":"publisher","first-page":"4464","DOI":"10.1016\/j.vaccine.2015.07.028","volume":"33","author":"G De Serres","year":"2015","unstructured":"De Serres G, Rouleau I, Skowronski DM, et al. Paresthesia and sensory disturbances associated with 2009 pandemic vaccine receipt: clinical features and risk factors. Vaccine. 2015;33(36):4464\u201371. https:\/\/doi.org\/10.1016\/j.vaccine.2015.07.028.","journal-title":"Vaccine"},{"issue":"6","key":"1354_CR25","doi-asserted-by":"publisher","first-page":"384","DOI":"10.4149\/bll_2012_088","volume":"113","author":"S Mistik","year":"2012","unstructured":"Mistik S, Balci E, Elmali F. Primary healthcare professionals\u2019 knowledge, attitude and behavior regarding influenza immunization; 2006\u20132007 season adverse effect profile. Bratisl Lek Listy. 2012;113(6):384\u20138. https:\/\/doi.org\/10.4149\/bll_2012_088.","journal-title":"Bratisl Lek Listy"},{"key":"1354_CR26","doi-asserted-by":"publisher","unstructured":"Salamanca de la Cueva I, Cinconze E, Eckermann T, et al. Safety profile of GSK's inactivated quadrivalent seasonal influenza vaccine in Belgium, Germany and Spain: passive enhanced safety surveillance study for the 2019\/2020 influenza season. Drug Saf. 2021;44(12):1375\u201390. https:\/\/doi.org\/10.1007\/s40264-021-01121-8.","DOI":"10.1007\/s40264-021-01121-8"},{"issue":"52","key":"1354_CR27","doi-asserted-by":"publisher","first-page":"8362","DOI":"10.1016\/j.vaccine.2020.11.004","volume":"38","author":"Y Sun","year":"2020","unstructured":"Sun Y, Li H, Pei Z, et al. Incidence of community-acquired pneumonia in urban China: a national population-based study. Vaccine. 2020;38(52):8362\u201370. https:\/\/doi.org\/10.1016\/j.vaccine.2020.11.004.","journal-title":"Vaccine"},{"issue":"29","key":"1354_CR28","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1016\/j.vaccine.2015.05.008","volume":"33","author":"LM Christian","year":"2015","unstructured":"Christian LM, Porter K, Karlsson E, Schultz-Cherry S. Proinflammatory cytokine responses correspond with subjective side effects after influenza virus vaccination. Vaccine. 2015;33(29):3360\u20136. https:\/\/doi.org\/10.1016\/j.vaccine.2015.05.008.","journal-title":"Vaccine"},{"key":"1354_CR29","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.3389\/fmicb.2016.01841","volume":"7","author":"A Bahadoran","year":"2016","unstructured":"Bahadoran A, Lee SH, Wang SM, et al. Immune responses to influenza virus and its correlation to age and inherited factors. Front Microbiol. 2016;7:1841. https:\/\/doi.org\/10.3389\/fmicb.2016.01841.","journal-title":"Front Microbiol"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-026-01354-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-026-01354-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-026-01354-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T12:50:40Z","timestamp":1779972640000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-026-01354-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1354"],"URL":"https:\/\/doi.org\/10.1007\/s40121-026-01354-z","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"12 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have declared no conflicts of interest. Hongxing Pan, Mingwei Wei, Yu Pan, Kangning Wang, Ming Li, Shaowen Tang, Qianqian Huang, Hongying Chen, Zengqiang Kou, Na Xie, Xiang Guo, Jing An, Jikai Zhang, A Kezhong and Yanjun Chen have nothing to disclose. Youcai An, Liuyang Kang and Hang Tao are employees of Ab&B Biotech Co., Ltd.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study adheres to the ethical principles for medical research involving human participants as outlined in the Declaration of Helsinki. This study was reviewed and approved by the Ethics Committees of the Provincial and Municipal Centers for Disease Control and Prevention in Jiangsu (JSJK2023-B016-02), Shanghai (KY-2023-58), Shandong (SDJK2023-036-02), Guangdong (2023V004-F), Hubei (2023-022-02), Xinjiang (P2024-002), Gansu (use JSJK2023-B016-02 for filing), and Qinghai (use JSJK2023-B016-02 for filing).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}